Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TP53 | P04637 | 3/20 | 0.69 |
| ▸ | SLC6A5 | Q9Y345 | 11/20 | 0.64 |
| ▸ | HTR2A | P28223 | 2/20 | 0.52 |
| ▸ | P2RX3 | P56373 | 1/20 | 0.51 |
| ▸ | LMNA | P02545 | 1/20 | 0.47 |
| ▸ | OPRM1 | P35372 | 1/20 | 0.45 |
| ▸ | OPRD1 | P41143 | 1/20 | 0.45 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.45 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.44 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2292348 | 0.92 | TP53 (0.77) | TP53SLC6A5HTR2AP2RX3LMNA | |
| SCHEMBL5017789 | 0.82 | TP53 (1.00) | TP53SLC6A5HTR2AP2RX3LMNA | |
| SCHEMBL2289214 | 0.81 | TP53 (0.58) | TP53SLC6A5LMNAOPRM1OPRD1 | |
| SCHEMBL4244675 | 0.81 | TP53 (0.58) | TP53SLC6A5HTR2AP2RX3L3MBTL1 | |
| SCHEMBL4244663 | 0.81 | TP53 (0.58) | TP53SLC6A5HTR2AP2RX3L3MBTL1 | |
| SCHEMBL5022323 | 0.79 | SLC6A5 (1.00) | TP53SLC6A5HTR2AP2RX3LMNA | |
| SCHEMBL4603996 | 0.78 | TP53 (0.55) | TP53SLC6A5HTR2AP2RX3L3MBTL1 | |
| SCHEMBL5017983 | 0.78 | TP53 (0.81) | TP53SLC6A5HTR2AP2RX3LMNA | |
| SCHEMBL5015969 | 0.78 | SLC6A5 (1.00) | TP53SLC6A5HTR2AP2RX3OPRM1 | |
| SCHEMBL3230103 | 0.77 | TP53 (0.54) | TP53SLC6A5HTR2AP2RX3L3MBTL1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8003699-B2 | Amide compound and use thereof for controlling plant diseases | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2011-08-23 | — | — | US | disclosed |
| US-20100105647-A1 | AMIDE COMPOUND AND USE THEREOF FOR CONTROLLING PLANT DISEASES | SUMITOMO CHEMICAL COMPANY, LIMITED | 2010-04-29 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100105647-A1 | AMIDE COMPOUND AND USE THEREOF FOR CONTROLLING PLANT DISEASES | CYC1, CBR3, CBR1 | TP53 4023/4885SLC6A5 4673/4885HTR2A 2876/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.